Cutting Edge: HMG-1 as a Mediator of Acute Lung Inflammation, The Journal of Immunology, vol.165, issue.6, pp.2950-2954, 2000. ,
DOI : 10.4049/jimmunol.165.6.2950
HMGB-1, A DNA-BINDING PROTEIN WITH CYTOKINE ACTIVITY, INDUCES BRAIN TNF AND IL-6 PRODUCTION, AND MEDIATES ANOREXIA AND TASTE AVERSION, Cytokine, vol.18, issue.4, pp.231-236, 2002. ,
DOI : 10.1006/cyto.2002.0890
Tissue-Type Plasminogen Activator Crosses the Intact Blood-Brain Barrier by Low-Density Lipoprotein Receptor-Related Protein-Mediated Transcytosis, Circulation, vol.111, issue.17, pp.2241-2249, 2005. ,
DOI : 10.1161/01.CIR.0000163542.48611.A2
URL : https://hal.archives-ouvertes.fr/hal-00542121
Oxygen Glucose Deprivation Switches the Transport of tPA Across the Blood-Brain Barrier From an LRP-Dependent to an Increased LRP-Independent Process, Stroke, vol.36, issue.5, pp.1065-1070, 2005. ,
DOI : 10.1161/01.STR.0000163050.39122.4f
URL : https://hal.archives-ouvertes.fr/hal-00542010
Anti-NR1 N-terminal-domain vaccination unmasks the crucial action of tPA on NMDA-receptor-mediated toxicity and spatial memory, Journal of Cell Science, vol.120, issue.4, pp.578-585, 2007. ,
DOI : 10.1242/jcs.03354
URL : https://hal.archives-ouvertes.fr/hal-00178289
Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion, The EMBO Journal, vol.22, issue.20, pp.5551-5560, 2003. ,
DOI : 10.1093/emboj/cdg516
Intercommunications between brain capillary endothelial cells and glial cells increase the transcellular permeability of the blood-brain barrier during ischaemia, Journal of Neurochemistry, vol.9, issue.4, pp.807-817, 2002. ,
DOI : 10.1046/j.1471-4159.2002.01186.x
URL : https://hal.archives-ouvertes.fr/hal-00525298
Regulation of DNA-Dependent Activities by the Functional Motifs of the High-Mobility-Group Chromosomal Proteins, Molecular and Cellular Biology, vol.19, issue.8, pp.5237-5246, 1999. ,
DOI : 10.1128/MCB.19.8.5237
Cerebrovascular protection as a possible mechanism for the protective effects of NXY-059 in preclinical models: An in vitro study, Brain Research, vol.1294, pp.144-152, 2009. ,
DOI : 10.1016/j.brainres.2009.07.035
URL : https://hal.archives-ouvertes.fr/hal-00544037
An Easier, Reproducible, and Mass-Production Method to Study the Blood?Brain Barrier In Vitro, Journal of Neurochemistry, vol.214, issue.5, pp.1798-1801, 1990. ,
DOI : 10.1002/jemt.1060010412
URL : https://hal.archives-ouvertes.fr/hal-00523911
Drug Transfer Across the Blood-Brain Barrier: Correlation Between In Vitro and In Vivo Models, Journal of Neurochemistry, vol.2, issue.5, pp.1790-1797, 1992. ,
DOI : 10.1038/285041a0
URL : https://hal.archives-ouvertes.fr/hal-00529693
Pathobiology of ischaemic stroke: an integrated view, Trends in Neurosciences, vol.22, issue.9, pp.391-397, 1999. ,
DOI : 10.1016/S0166-2236(99)01401-0
High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo, Journal of Neurochemistry, vol.297, issue.part 1, pp.590-603, 2007. ,
DOI : 10.1111/j.1471-4159.2007.04788.x
Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke, New England Journal of Medicine, vol.359, issue.13, pp.1317-1329, 2008. ,
DOI : 10.1056/NEJMoa0804656
Delayed Treatment With Minocycline Ameliorates Neurologic Impairment Through Activated Microglia Expressing a High-Mobility Group Box1-Inhibiting Mechanism, Stroke, vol.39, issue.3, pp.951-958, 2008. ,
DOI : 10.1161/STROKEAHA.107.495820
Role of ERK map kinase and CRM1 in IL- 1beta-stimulated release of HMGB1 from cortical astrocytes, Glia, vol.58, pp.1007-1015, 2010. ,
Biphasic actions of HMGB1 signaling in inflammation and recovery after stroke, Annals of the New York Academy of Sciences, vol.35, issue.1, pp.50-57, 2010. ,
DOI : 10.1111/j.1749-6632.2010.05728.x
HMGB1, a Novel Cytokine-Like Mediator Linking Acute Neuronal Death and Delayed Neuroinflammation in the Postischemic Brain, Journal of Neuroscience, vol.26, issue.24, pp.6413-6421, 2006. ,
DOI : 10.1523/JNEUROSCI.3815-05.2006
Regulation of Brain Proteolytic Activity Is Necessary for the In Vivo Function of NMDA Receptors, Journal of Neuroscience, vol.24, issue.43, pp.9734-9743, 2004. ,
DOI : 10.1523/JNEUROSCI.3306-04.2004
A signature for the HMG-1 box DNA-binding proteins, BioEssays, vol.12, issue.8, pp.539-546, 1993. ,
DOI : 10.1002/bies.950150807
Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats, The FASEB Journal, vol.21, issue.14, pp.3904-3916, 2007. ,
DOI : 10.1096/fj.07-8770com
Recombinant Desmodus rotundus Salivary Plasminogen Activator Crosses the Blood-Brain Barrier Through a Low-Density Lipoprotein Receptor-Related Protein-Dependent Mechanism Without Exerting Neurotoxic Effects, Stroke, vol.38, issue.3, pp.1036-1043, 2007. ,
DOI : 10.1161/01.STR.0000258100.04923.84
URL : https://hal.archives-ouvertes.fr/hal-00543483
Toward Safer Thrombolytic Agents in Stroke: Molecular Requirements for NMDA Receptor-Mediated Neurotoxicity, Journal of Cerebral Blood Flow & Metabolism, vol.384, issue.6, pp.1212-1221, 2008. ,
DOI : 10.1056/NEJM199512143332401
The HMGB1 Receptor RAGE Mediates Ischemic Brain Damage, Journal of Neuroscience, vol.28, issue.46, pp.12023-12031, 2008. ,
DOI : 10.1523/JNEUROSCI.2435-08.2008
Peroxisome Proliferator-Activated Receptor-α Activation Protects Brain Capillary Endothelial Cells from Oxygen-Glucose Deprivation-Induced Hyperpermeability in the Blood-Brain Barrier, Current Neurovascular Research, vol.6, issue.3, pp.181-193, 2009. ,
DOI : 10.2174/156720209788970081
The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling, Nat. Med, vol.7, pp.59-64, 2001. ,
Interactions of plasminogen and tissue plasminogen activator (t-PA) with amphoterin. Enhancement of t-PA-catalyzed plasminogen activation by amphoterin, J. Biol. Chem, vol.266, pp.16730-16735, 1991. ,
Early Release of HMGB-1 from Neurons after the Onset of Brain Ischemia, Journal of Cerebral Blood Flow & Metabolism, vol.78, issue.5, pp.927-938, 2008. ,
DOI : 10.1126/science.285.5425.248
High-Mobility Group Box 1 Promotes Metalloproteinase-9 Upregulation Through Toll-Like Receptor 4 After Cerebral Ischemia, Stroke, vol.41, issue.9, pp.2077-2082, 2010. ,
DOI : 10.1161/STROKEAHA.110.590463
Analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (amphoterin), Journal of Leukocyte Biology, vol.81, issue.1, pp.49-58, 2007. ,
DOI : 10.1189/jlb.0306200
Tissue-Type Plasminogen Activator: A Multifaceted Modulator of Neurotransmission and Synaptic Plasticity, Neuron, vol.50, issue.5, pp.673-678, 2006. ,
DOI : 10.1016/j.neuron.2006.04.013
Tissue-type plasminogen activator requires a co-receptor to enhance NMDA receptor function, Journal of Neurochemistry, vol.20, pp.1091-1101, 2008. ,
DOI : 10.1111/j.1471-4159.2008.05687.x
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198853
Symptomatic intracerebral hemorrhage and recanalization after IV rt-PA: A multicenter study, Neurology, vol.71, issue.17, pp.1304-1312, 2008. ,
DOI : 10.1212/01.wnl.0000313936.15842.0d
HMGB1 Develops Enhanced Proinflammatory Activity by Binding to Cytokines, The Journal of Immunology, vol.180, issue.4, pp.2531-2537, 2008. ,
DOI : 10.4049/jimmunol.180.4.2531
Pharmacokinetics and systemic effects of tissue-type plasminogen activator in normal subjects, Clinical Pharmacology and Therapeutics, vol.46, issue.2, pp.155-162, 1989. ,
DOI : 10.1038/clpt.1989.120
Toll-like receptor 9???dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE, Nature Immunology, vol.198, issue.5, pp.487-496, 2007. ,
DOI : 10.1038/ni1457
Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator, Nature, vol.377, issue.6547, pp.340-344, 1995. ,
DOI : 10.1038/377340a0
The plasminogen activator/plasmin system., Journal of Clinical Investigation, vol.88, issue.4, pp.1067-1072, 1991. ,
DOI : 10.1172/JCI115405
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice, Science, vol.285, issue.5425, pp.248-251, 1999. ,
DOI : 10.1126/science.285.5425.248
Targeting Extracellular Matrix Proteolysis for Hemorrhagic Complications of tPA Stroke Therapy, CNS & Neurological Disorders - Drug Targets, vol.7, issue.3, pp.235-242, 2008. ,
DOI : 10.2174/187152708784936635
Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic, Trends in Neurosciences, vol.32, issue.1, pp.48-55, 2009. ,
DOI : 10.1016/j.tins.2008.09.006
URL : https://hal.archives-ouvertes.fr/inserm-01296642